will share a poster presentation on immune checkpoint enhancer (ICE), ALTB-168, during Digestive Disease Week ®, taking place at McCormick Place in Chicago, IL, from May 6-9, 2023. Dr. Rubin will ...

The poster will be available for viewing during the DDW exhibition, and details are as follows: Title: Interim PK Data for SPY001, a Novel Half-Life Extended Monoclonal Antibody Targeting α4β7 ...

CINCINNATI--(BUSINESS WIRE)--CinDome Pharma, a CinRx portfolio company, will present a poster at the 2023 Digestive Disease Week (DDW) Conference, held May 6 th – 9 th in Chicago, Illinois.

at the upcoming Digestive Disease Week Conference (DDW), to be held May 3-6, 2025, in San Diego. IBSRELA is approved by the U.S. Food and Drug Administration to treat irritable bowel syndrome with ...

SPY001 is a novel, half-life extended α4β7 antibody in development for the treatment of Inflammatory Bowel Disease (IBD) SPY001 pharmacokinetic (PK) data up to eight months continues to support ...

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...